Cargando…
Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
OBJECTIVE: The Action to Control Cardiovascular Risk in Diabetes lipid study (ACCORD Lipid), which compared the effects of simvastatin plus fenofibrate (FENO-S) versus simvastatin plus placebo (PL-S) on cardiovascular disease outcomes, measured only fasting triglyceride (TG) levels. We examined the...
Autores principales: | Reyes-Soffer, Gissette, Ngai, Colleen I., Lovato, Laura, Karmally, Wahida, Ramakrishnan, Rajasekhar, Holleran, Stephen, Ginsberg, Henry N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554305/ https://www.ncbi.nlm.nih.gov/pubmed/23033246 http://dx.doi.org/10.2337/dc11-2556 |
Ejemplares similares
-
Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
por: Matveyenko, Anastasiya, et al.
Publicado: (2023) -
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans
por: Reyes-Soffer, Gissette, et al.
Publicado: (2017) -
Dietary Impact on Postprandial Lipemia
por: Bozzetto, Lutgarda, et al.
Publicado: (2020) -
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects
por: Thomas, Tiffany, et al.
Publicado: (2017) -
Postprandial lipemia in pre- and postmenopausal women
por: Zaman, Gaffar S., et al.
Publicado: (2012)